CureImmune Therapeutics Inc.
$137,838.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2018-2019
Canada
The goal of the project is to develop broadly effective immune therapeutic agents for the treatment of cancer.